Cgp-71683A

Cgp-71683A

SCHEMBL326665

Nc1nc(NCC2CCC(CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 19/20 1.00
ADRA2A P08913 3/20 1.00
AQP1 P29972 2/20 1.00
MCHR1 Q99705 2/20 1.00
NPY1R P25929 2/20 1.00
ALDH1A1 P00352 1/20 1.00
MAPT P10636 1/20 1.00
HPGD P15428 1/20 1.00
NPY2R P49146 1/20 1.00
NPY4R P50391 1/20 1.00
TDP1 Q9NUW8 1/20 1.00
SLC6A4 P31645 2/20 0.72
AGTR1 P30556 1/20 0.66
AGTR2 P50052 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cgp-71683A SCHEMBL29430173 1.00 NPY5R (1.00) NPY5RADRA2AAQP1MCHR1NPY1R
Cgp-71683A SCHEMBL30480660 1.00 NPY5R (1.00) NPY5RADRA2AAQP1MCHR1NPY1R
Cgp-71683A SCHEMBL29440034 0.99 NPY5R (0.98) NPY5RADRA2AAQP1MCHR1NPY1R
Cgp-71683A SCHEMBL225992 0.99 NPY5R (0.98) NPY5RADRA2AAQP1MCHR1NPY1R
SCHEMBL13796726 0.88 NPY5R (0.78) NPY5RADRA2AAQP1MCHR1NPY1R
SCHEMBL8900731 0.87 NPY5R (0.81) NPY5RADRA2AAQP1MCHR1NPY1R
SCHEMBL8900726 0.87 NPY5R (0.81) NPY5RADRA2AAQP1MCHR1NPY1R
SCHEMBL8898897 0.86 NPY5R (0.75) NPY5RADRA2AAQP1MCHR1NPY1R
Hydrochloric Acid SCHEMBL8900603 0.86 NPY5R (0.81) NPY5RADRA2AAQP1MCHR1NPY1R
Hydrochloric Acid SCHEMBL8900606 0.86 NPY5R (0.81) NPY5RADRA2AAQP1MCHR1NPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582709-B1 AZOLOPYRIDIN-3-ONE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES SANOFI SA (FR) 2018-01-24 EP disclosed
EP-2683698-B1 BENZYL-OXATHIAZINE DERIVATES SUBSTITUTED WITH ADAMANTANE OR NORADAMANTANE, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF SANOFI SA (FR) 2017-10-04 EP disclosed
EP-2203416-B1 (CARBOXY ALKYLENE-PHENYL)-PHENYL-OXALAMIDES, METHOD FOR THEIR MANUFACTURE AND THEIR APPLICATION AS MEDICINES SANOFI SA (FR) 2016-10-26 EP disclosed
EP-2203415-B1 (CYCLOPROPYL-PHENYL)-PHENYL-OXALAMIDES, METHOD FOR THEIR MANUFACTURE AND THEIR APPLICATION AS MEDICINES SANOFI SA (FR) 2016-10-26 EP disclosed
EP-2144885-B1 IMIDAZOLIDINE CARBOXAMIDE DERIVATIVES AS LIPASE AND PHOSPHOLIPASE INHIBITORS SANOFI SA (FR) 2016-06-29 EP disclosed
EP-2144891-B1 5-OXO-ISOXAZOLES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES SANOFI SA (FR) 2016-06-15 EP disclosed
EP-2766349-B1 OXATHIAZINE DERIVATIVES SUBSTITUTED WITH CARBOCYCLES OR HETEROCYCLES, METHOD FOR PRODUCING SAME, DRUGS CONTAINING SAID COMPOUNDS, AND USE THEREOF SANOFI SA (FR) 2016-06-01 EP disclosed
EP-2683699-B1 DI- AND TRI-SUBSTITUTED OXATHIAZINE DERIVATES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS MEDICINE AND DRUG CONTAINING SAID DERIVATIVES AND USE THEREOF SANOFI SA (FR) 2015-06-24 EP disclosed
EP-1940807-B1 CARBAMOYLBENZOTRIAZOLE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES SANOFI SA (FR) 2015-06-17 EP disclosed
EP-2683703-B1 NOVEL SUBSTITUTED PHENYL-OXATHIAZINE DERIVATIVES, METHOD FOR PRODUCING THEM, DRUGS CONTAINING SAID COMPOUNDS AND THE USE THEREOF SANOFI SA (FR) 2015-05-27 EP disclosed
WO-2005073230-A1 HETEROCYCLICALLY SUBSTITUTED 7-AMINO-4-QUINOLONE-3-CARBOXYLIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-08-11 WO disclosed
EP-1523471-A1 UREA-SUBSTITUTED AND URETHANE-SUBSTITUTED ACYLUREAS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2005-04-20 EP disclosed
EP-1513800-A1 N-BENZOYLUREIDOCINNAMATE DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF Aventis Pharma Deutschland GmbH (DE) 2005-03-16 EP disclosed
WO-2004087655-A1 NOVEL DIPHENYL AZETIDINONE WITH IMPROVED PHYSIOLOGICAL CHARACTERISTICS, CORRESPONDING PRODUCTION METHOD, MEDICAMENTS CONTAINING SAID COMPOUND AND USE OF THE LATTER SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2004-10-14 WO disclosed
WO-2004078743-A1 SUBSTITUTED BENZOYLUREIDOPYRIDYL-PIPERIDINE AND -PYRROLIDINE CARBOXYLIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-09-16 WO disclosed
WO-2004072060-A1 SUBSTITUTED 3-(BENZOYLUREIDO)-THIOPHENE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-08-26 WO disclosed
WO-2004065387-A1 PYRIMIDO[5,4-E][1,2,4]TRIAZINE-5,7-DIONES, METHODS FOR PRODUCING THE SAME AND THEIR USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-08-05 WO disclosed
WO-2004065356-A1 CARBONYL-AMINO SUBSTITUTED ACYL PHENYL UREA DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-08-05 WO disclosed
WO-2004007437-A1 UREA-SUBSTITUTED AND URETHANE-SUBSTITUTED ACYLUREAS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-01-22 WO disclosed
WO-2003104188-A1 N-BENZOYLUREIDOCINNAMATE DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-18 WO disclosed